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As an individual diagnosed with idiopathic hypersomnia (IH), I read the recently proposed suggestions for 
reclassifying the central disorders of hypersomnolence1 with great interest. Here, I allude to the article by 
Fronczek and colleagues1 entitled “To split or to lump? Classifying the central disorders of hypersomnolence”. 
Whilst I concur with the merging of narcolepsy type-2 (NT2) and idiopathic hypersomnia without long sleep 
duration, long sleeping individuals with IH remain overlooked.   
Hypersomnias of central origin are characterised by marked deficits in the ability to remain awake at an 
appropriate time though the diurnal period. More typically, these disorders are quantified by the pathological 
nature of excessive daytime sleepiness (EDS), an increased propensity to fall asleep.2-3 Like narcolepsy, 
idiopathic hypersomnia is an equally debilitating condition that commonly presents alongside additional 
ailments which include: long and unrefreshing naps, longer nocturnal sleep, difficulties in awakening, 
excessive sleep inertia, and impaired neuropsychological function.4-5 For example, IH patients frequently self-
report: sleep inertia (82.5%), unrefreshing nocturnal sleep (97.5%) and naps (73.8%) and multiple alarm use 
(57.2%).4-5 
 
Unfortunately, from a diagnostic perspective, confirmation of IH largely relies on the objective quantification 
of EDS using the Multiple Sleep Latency Test (MSLT). Whilst the MSLT remains a useful tool for the diagnosis 
of narcolepsy type-1 (NT1), poor test-retest reliability limits adequate determination of NT2 and IH.6-10 For 
example, in NT2 subjects completing the MSLT at two time points, only 18% of individuals consistently 
indicated NT2 with the second test changing diagnosis to idiopathic hypersomnia in 26% of cases or a negative 
MSLT in 57%.11 Moreover, mixed evidence regarding the observation of low mean sleep-onset latency (SOL) 
in idiopathic hypersomnia further questions the utility of the MSLT in this population.10 However, limitations 
of the MSLT when assessing idiopathic hypersomnia may not be a failure of the test itself, but rather a lack of 
understanding the aetiology of the disorder and consensus regarding the agreed criteria. That said, where 
mean SOL outcomes of ≤8 are not observed using the MSLT, the precedingly recorded objective sleep data 
(either by polysomnography or actigraphy) may confirm a diagnosis of IH. More specifically, where ≥ 11 hours 
of sleep time per 24-h period occurs at least three times over the course of a week. Nevertheless, it’s 
recommended that clinicians should use their own judgment when presented with all possible data, 
particularly the use of additional soft criteria among those failing to meet the ≤8 sleep-onset latency.12,13 
Whilst a repeat MSLT is recommended in borderline patients, the aforementioned issues may limit its utility. 
Therefore, it is vital for the next revision of diagnostic criterion of IH to formally re-examine the ≤8-minute 
mean MSLT sleep-onset latency cut-off, multiple testing and examination of additional symptoms (i.e. 
unrefreshing naps, sleep inertia, cognitive functional deficits, sleep paralysis and hallucinations) to aid 
diagnosis. 
 
Based partially on these observations, Fronczek and colleagues1 propose the NT2 classification to be replaced 
by ‘Narcolepsy Spectrum Disorder’. Here, IH with short sleep duration and NT2 would become merged where 
positive screening would no longer rely on the frequency of sleep-onset REM periods (SOREMPs). Certainly, 
this reclassification would benefit those who would otherwise be diagnosed with IH. Most notably, access to 
pharmacological treatments that are currently restricted to those with NT1 or NT2 such as (e.g. sodium 
oxybate). However, the categorical term ‘Narcolepsy Spectrum Disorder’ appears somewhat juxtaposed 
considering the linear divergence in symptom presentation between NT1, NT2 and IH. If central disorders of 
hypersomnolence are rebranded, then why not simplify re-categorisation. Rather than ‘Narcolepsy Type-1’, 
Narcolepsy Spectrum Disorder’, and ‘Idiopathic Hypersomnia’, in line with the spectral nature of 
hypersomnolence disorders, the case for ‘Narcolepsy Type-1, Type-2, and Type-3’ is perhaps more compelling 
(see Figure 1). Indeed, long sleeping individuals with IH would fail to benefit from the initially prosed 
reclassification.1 Renaming the proposed IH classification to ‘Narcolepsy Type-3’ (NT3), would come with a 
number of benefits. First, like myself, many people with IH experience great stigma and difficulties in 
explaining the nature of the disorder to others.14 Idiopathic hypersomnia is not a term that the majority of the 
general public are familiar with. I consistently find myself explaining “it’s like narcolepsy” before an individual 
comes to the realisation that IH is indeed a sleep disorder. Second, a classification of NT3 may serve to increase 
research in this area with greater inclusion of the IH (or NT3) population in comparative studies of narcolepsy 
subtypes. Finally, reclassification of IH to NT3 may provide region-specific benefits (e.g. reimbursement of 
treatment offered in the US) and consideration of pharmacological options which in some countries are 
currently limited to those with NT1 and NT2.   
 
To summarise, I would like to thank Fronczek and colleagues1 for their important work highlighting the need 
to reclassifying the central disorders of hypersomnolence. Whilst the proposed merging NT2 and IH without 
long sleep duration is certainly overdue, it is important to also consider the remaining IH group. A more 
simplified classification should be considered moving forward, one which would include IH in the narcolepsy 
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Figure 1. [Top row] Current International Classification of Sleep Disorders, third edition, versus proposed 
grouping. The ICSD-3 lists eight central disorders of hypersomnolence, including narcolepsy type 1, narcolepsy 
type 2, and idiopathic hypersomnia. [Bottom Row] Combination of those with narcolepsy type 2 and those 
with idiopathic hypersomnia without long sleep time into “Narcolepsy Type-2” as proposed by Fronczek and 
colleagues.1 Proposed relabelling of Idiopathic hypersomnia with long sleep to “Narcolepsy Type-3”. 
